335 related articles for article (PubMed ID: 17593069)
1. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain.
Nyrop KA; Palsson OS; Levy RL; Von Korff M; Feld AD; Turner MJ; Whitehead WE
Aliment Pharmacol Ther; 2007 Jul; 26(2):237-48. PubMed ID: 17593069
[TBL] [Abstract][Full Text] [Related]
2. Annual Costs of Care for Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, and Functional Abdominal Pain Syndrome.
Hoekman DR; Rutten JM; Vlieger AM; Benninga MA; Dijkgraaf MG
J Pediatr; 2015 Nov; 167(5):1103-8.e2. PubMed ID: 26329806
[TBL] [Abstract][Full Text] [Related]
3. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.
van Tilburg MA; Palsson OS; Levy RL; Feld AD; Turner MJ; Drossman DA; Whitehead WE
BMC Complement Altern Med; 2008 Jul; 8():46. PubMed ID: 18652682
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
5. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Buono JL; Mathur K; Averitt AJ; Andrae DA
J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
[TBL] [Abstract][Full Text] [Related]
6. Economic burden attributable to functional bowel disorders in Iran: a cross-sectional population-based study.
Moghimi-Dehkordi B; Vahedi M; Pourhoseingholi MA; Khoshkrood Mansoori B; Safaee A; Habibi M; Pourhoseingholi A; Zali MR
J Dig Dis; 2011 Oct; 12(5):384-92. PubMed ID: 21955432
[TBL] [Abstract][Full Text] [Related]
7. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
[TBL] [Abstract][Full Text] [Related]
8. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
9. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.
Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT; Doshi JA
J Med Econ; 2014 Feb; 17(2):148-58. PubMed ID: 24168640
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study.
Coban Ş; Akbal E; Köklü S; Köklü G; Ulaşlı MA; Erkeç S; Aktaş B; Yüksel O; Koçak E; Erdem HR
Digestion; 2012; 86(2):86-93. PubMed ID: 22846190
[TBL] [Abstract][Full Text] [Related]
11. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
[TBL] [Abstract][Full Text] [Related]
12. Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.
Flik CE; Laan W; Smout AJ; Weusten BL; de Wit NJ
BMC Gastroenterol; 2015 Nov; 15():168. PubMed ID: 26612205
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
14. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
[TBL] [Abstract][Full Text] [Related]
15. Treatment of irritable bowel syndrome. A case control experience.
Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
[TBL] [Abstract][Full Text] [Related]
16. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.
Heidelbaugh JJ; Stelwagon M; Miller SA; Shea EP; Chey WD
Am J Gastroenterol; 2015 Apr; 110(4):580-7. PubMed ID: 25781368
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population.
Guerin A; Carson RT; Lewis B; Yin D; Kaminsky M; Wu E
J Med Econ; 2014 Aug; 17(8):577-86. PubMed ID: 24811855
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
20. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
